- $1.44bn
- $10.62bn
- $1.05bn
- 44
- 87
- 30
- 53
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 325 | 553 | 402 | 714 | 1,049 |
Cost of Revenue | |||||
Gross Profit | 116 | 241 | 165 | 262 | 251 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 270 | 482 | 361 | 615 | 765 |
Operating Profit | 54.3 | 70.6 | 40.8 | 99.4 | 284 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 64.5 | 54.5 | 132 | 175 | 358 |
Provision for Income Taxes | |||||
Net Income After Taxes | 75.1 | 46.1 | 117 | 160 | 351 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 73 | 44.9 | 158 | 194 | 339 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 72.3 | 43.5 | 141 | 177 | 334 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.3 | 0.935 | 1.65 | 1.29 | 1.12 |
Dividends per Share |